New Therapies for Hormone-Sensitive Advanced Breast Cancer
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Outline the current and upcoming therapies for hormone-sensitive advanced breast cancer
Ingrid A. Mayer, MD, MSCI
Vanderbilt-Ingram Cancer Center
- 1.00 Participation
- 0.88 Nurse
- 1.00 Pharmacist
- 1.00 Physician